EPLR 3/2021 Out Now
The third issue of the European Pharmaceutical Law Review in 2021 is now available. The issue features the following articles, reports and case notes:
- Reconsidering Repositioning Incentives: An Empirical Legal Analysis of Market Protection for New Therapeutic Indications
- Medicinal Products and the Screening of Foreign Direct Investment
- New Clinical Trial Rules in the EU: A Practical Overview of the Upcoming Regulation
- The Interpretation in France of Causation in Tort Liability Litigations Involving Medical Matters
- Pharmacovigilance: Historical Evolution, Legal Frame and Function During the Covid Era
View the whole table of content of EPLR 3/2021: Here
Become an Author for EPLR and view our Call for Papers